PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs.
Saved in:
| Title: | PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs. |
|---|---|
| Authors: | Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pepe F; Department of Public Health, Federico II University of Naples, Naples, Italy., Nacchio M; Department of Public Health, Federico II University of Naples, Naples, Italy., Palumbo L; Department of Public Health, Federico II University of Naples, Naples, Italy., Pisapia P; Department of Public Health, Federico II University of Naples, Naples, Italy., De Camilli E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Castellano I; Unit of Pathology, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy., Cerbelli B; Department of Medical-Surgical Sciences and Biotechnologies Sapienza University of Rome, Rome, Italy., Costarelli L; Unit of Pathology, San Giovanni-Addolorata Hospital, Rome, Italy., d'Amati G; Department of Medical-Surgical Sciences and Biotechnologies Sapienza University of Rome, Rome, Italy., Rizzo A; Division of Pathology, Clinical Institute Humanitas Catania, Misterbianco (CT), Italy., Santinelli A; Unit of Anatomic Pathology, Azienda Sanitaria Territoriale di Pesaro-Urbino, Pesaro, Italy., Scatena C; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., De Angelis C; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy., Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Department of Oncology 2, Veneto Institute of Oncology IOV IRCCS, Padova, Italy., Troncone G; Department of Public Health, Federico II University of Naples, Naples, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Viale G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Malapelle U; Department of Public Health, Federico II University of Naples, Naples, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. |
| Corporate Authors: | PIK3CA in breast cancer GIPaM/PMMP cooperative group |
| Source: | Pathologica [Pathologica] 2025 Dec; Vol. 117 (6), pp. 571-579. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41954342 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mane+E%22">Mane E</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cursano+G%22">Cursano G</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Venetis+K%22">Venetis K</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Frascarelli+C%22">Frascarelli C</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pepe+F%22">Pepe F</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Nacchio+M%22">Nacchio M</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Palumbo+L%22">Palumbo L</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Pisapia+P%22">Pisapia P</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22De+Camilli+E%22">De Camilli E</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Castellano+I%22">Castellano I</searchLink>; Unit of Pathology, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Cerbelli+B%22">Cerbelli B</searchLink>; Department of Medical-Surgical Sciences and Biotechnologies Sapienza University of Rome, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Costarelli+L%22">Costarelli L</searchLink>; Unit of Pathology, San Giovanni-Addolorata Hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22d'Amati+G%22">d'Amati G</searchLink>; Department of Medical-Surgical Sciences and Biotechnologies Sapienza University of Rome, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+A%22">Rizzo A</searchLink>; Division of Pathology, Clinical Institute Humanitas Catania, Misterbianco (CT), Italy.<br /><searchLink fieldCode="AU" term="%22Santinelli+A%22">Santinelli A</searchLink>; Unit of Anatomic Pathology, Azienda Sanitaria Territoriale di Pesaro-Urbino, Pesaro, Italy.<br /><searchLink fieldCode="AU" term="%22Scatena+C%22">Scatena C</searchLink>; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Criscitiello+C%22">Criscitiello C</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22De+Angelis+C%22">De Angelis C</searchLink>; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Dieci+MV%22">Dieci MV</searchLink>; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Department of Oncology 2, Veneto Institute of Oncology IOV IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Troncone+G%22">Troncone G</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Viale+G%22">Viale G</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Guerini-Rocco+E%22">Guerini-Rocco E</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Malapelle+U%22">Malapelle U</searchLink>; Department of Public Health, Federico II University of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Fusco+N%22">Fusco N</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22PIK3CA+in+breast+cancer+GIPaM%2FPMMP+cooperative+group%22">PIK3CA in breast cancer GIPaM/PMMP cooperative group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220401123%22">Pathologica</searchLink> [Pathologica] 2025 Dec; Vol. 117 (6), pp. 571-579. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pacini+Editore+SpA%22">Pacini Editore SpA </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0401123 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1591-951X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200312983%22">00312983 </searchLink><i>NLM ISO Abbreviation: </i>Pathologica <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41954342 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.32074/1591-951X-1603 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 571 Titles: – TitleFull: PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mane E – PersonEntity: Name: NameFull: Cursano G – PersonEntity: Name: NameFull: Venetis K – PersonEntity: Name: NameFull: Frascarelli C – PersonEntity: Name: NameFull: Pepe F – PersonEntity: Name: NameFull: Nacchio M – PersonEntity: Name: NameFull: Palumbo L – PersonEntity: Name: NameFull: Pisapia P – PersonEntity: Name: NameFull: De Camilli E – PersonEntity: Name: NameFull: Castellano I – PersonEntity: Name: NameFull: Cerbelli B – PersonEntity: Name: NameFull: Costarelli L – PersonEntity: Name: NameFull: d'Amati G – PersonEntity: Name: NameFull: Rizzo A – PersonEntity: Name: NameFull: Santinelli A – PersonEntity: Name: NameFull: Scatena C – PersonEntity: Name: NameFull: Criscitiello C – PersonEntity: Name: NameFull: De Angelis C – PersonEntity: Name: NameFull: Dieci MV – PersonEntity: Name: NameFull: Troncone G – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Viale G – PersonEntity: Name: NameFull: Guerini-Rocco E – PersonEntity: Name: NameFull: Malapelle U – PersonEntity: Name: NameFull: Fusco N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1591-951X Numbering: – Type: volume Value: 117 – Type: issue Value: 6 Titles: – TitleFull: Pathologica Type: main |
| ResultId | 1 |